The Asia Pacific is the fastest-growing region for diabetes drug market owing to growing the prevalence of diabetes in India and China increasing the demand of the glucose monitoring devices in this region. Approximately, 114 million in China and 72 million in India people suffer from diabetes. Furthermore, around 95% of people suffer from type 2 diabetes. Increasing prevalence of heart disease such as cholesterol, blood pressure is ... Read more
